Greetings all, I have applied to a few HC focused Investment Banks for Summer Analyst opportunities and I was wondering if anyone had a good resource for preparing for the technical portions? Is there a guide out there that focuses on HC focused techs????
| +267 | Why UBS Is the Worst Place to Start Your IB Career | 40 | 2d |
| +219 | UBS 2nd Year Analyst Q&A (2026) | 41 | 1d |
| +109 | UBS IB 26Q2 a Disaster! Advisory Revenue Down 23%, Capital MarketsDown 5% | 14 | 16m |
| +102 | What's your craziest "hardo" story? | 18 | 7h |
| +53 | Wolf of Wall Street vs. Reality: Anyone else feel scammed by the movies? | 19 | 21h |
| +50 | Suspended for a Year | 21 | 1d |
| +49 | Elite Boutique interview questions | 17 | 2d |
| +37 | so confused about 28 SA timeline | 30 | 16h |
| +37 | Lincoln International Return Offers | 9 | 5h |
| +33 | Rate my non-target resume | 19 | 10h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
if you google "m&i healthcare guide", it provides a great high level overview of the healthcare industry. it may not be technical heavy but i've found it's an excellent place to start.
SA here at a healthcare group. It really is important to show interest in hc. Its important to follow transactions and understand whats the industry like at a general pov. I would look up public companies that are under each of the main verticals (hc services/providers, medtech, biotech/pharma, life science tools, and healthcare IT) and find initiating coverage reports and learn the industry that way.
There isn't really too much in terms of technicals specific to hc besides biotech modeling.
Just converted a HC SA. I’d imagine being able to speak about the verticals (Life Sciences, Health Services and MedTech), recent big deals and some of the underlying science and a good answer for why healthcare would be a good start.
From what I understand, the only part of HC valuation that is different from basic valuation techniques is Biotech and BioPharma where you need to find your addressable populations, relevant subpopulations and apply a Probability of Success. You should probably know about how clinical trials work, how the FDA approves a drug etc. Be able to understand why DCF would be preferred to comps (obvious cause most don’t have revenues/EBITDA etc) and why an lbo is non sensical here
For news, fierce biotech and fiercebiopharma are good general websites.
Wait holy fuck, did I actually learn something over summer??
If you don't have revenues, why would a DCF be preferred because my thought process is that then you won't have FCF to base it off when you do a DCF. Wouldn't comps make more sense so that you look at other comparables with no revenue etc??
Thought I'd comment on this even though it's super late.
Comps are very hard for biotech. Many dont even have a P/E because no revenues are coming in, thus also making it hard to do P/Sales or EV/Sales
Instead, it's not unheard of to do a 20 year DCF for biotechs. That should give enough runway for the drug(s) to see FDA approval and you can project revenue up to peak, and drop it from there after the patent has expired or you suspect competitors will enter the market.
Remember, the valuation model isn't the end all be all. It reflects your assumptions for the company or drugs. Numbers can vary widely depending how much you risk adjust the drugs probability of success.
Take a look at EvaluatePharma's 2024 view for a big view of critical factors impacting HC. Also Lazard London publishes something useful every year. Take a look at that.
Also google "peak sales" and take a look at how to value companies that don't have revenues.
Also take a look at the more quirky deals and partnerships. Oncology is also a hot space.
Which HC focused banks did you apply to? I’m super interested in the space and want to apply to some HC focused banks.
Rerum alias ut veritatis odio maxime rerum blanditiis. Aspernatur dolores saepe amet a. Ut sed reiciendis veniam. Non aut nihil provident et culpa. Fuga dolorum molestiae possimus dignissimos.
Consequatur exercitationem distinctio voluptas id facere maiores. Eligendi et facilis aut vel rerum recusandae.
Iste eligendi et similique eaque eveniet accusantium. Iure aut molestias qui officiis. Sint odio sunt iusto iure totam. Cumque amet et impedit veritatis ullam deleniti exercitationem.
Nihil adipisci odio et qui earum non. Expedita qui perferendis nesciunt laudantium nesciunt. At sit aliquid officiis officiis ratione ea repellendus qui. Nisi vel omnis inventore quia iste quam quisquam. Voluptatem voluptate molestias sint et. Recusandae vero quam amet voluptas tenetur rem facilis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...